Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick L Ruberg

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
The American Journal of Cardiology|February 7, 2009
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosisFrederick L Ruberg, Evan Appelbaum, Ravin Davidoff, et al.
Blood Advances|August 15, 2023
Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosisJoshua N Gustine, Andrew Staron, Lisa Mendelson, et al.
The American Journal of Cardiology|March 7, 2006
An intracardiac accessory thyroid glandFrederick L Ruberg, Marie E McDonnell, Jeffrey Trabb, et al.
Circulation. Heart Failure|February 17, 2018
Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type TransthyretinJacquelyn L S Hanson, Marios Arvanitis, Clarissa M Koch, et al.
Circulation|December 15, 2015
Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort StudyLawreen H Connors, Flora Sam, Martha Skinner, et al.
Journal of the American College of Cardiology|October 31, 2025
Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance, Michelle M Kittleson, Amrut V Ambardekar, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 1, 2014
Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosisAzadeh Ahmadian, Ashley Brogan, Jeffrey Berman, et al.
JACC. Cardiooncology|January 29, 2021
Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell TransplantationGraham Lohrmann, Monica Arun Patel, Dina Brauneis, et al.
European Heart Journal. Cardiovascular Imaging|December 15, 2016
Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosisFrancesco Salinaro, Hans K Meier-Ewert, Edward J Miller, et al.
Circulation|January 24, 2008
Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart StudyGuido A Rosito, Joseph M Massaro, Udo Hoffmann, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
The American Journal of Cardiology|February 7, 2009
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosisFrederick L Ruberg, Evan Appelbaum, Ravin Davidoff, et al.
Blood Advances|August 15, 2023
Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosisJoshua N Gustine, Andrew Staron, Lisa Mendelson, et al.
The American Journal of Cardiology|March 7, 2006
An intracardiac accessory thyroid glandFrederick L Ruberg, Marie E McDonnell, Jeffrey Trabb, et al.
Circulation. Heart Failure|February 17, 2018
Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type TransthyretinJacquelyn L S Hanson, Marios Arvanitis, Clarissa M Koch, et al.
Circulation|December 15, 2015
Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort StudyLawreen H Connors, Flora Sam, Martha Skinner, et al.
Journal of the American College of Cardiology|October 31, 2025
Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance, Michelle M Kittleson, Amrut V Ambardekar, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 1, 2014
Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosisAzadeh Ahmadian, Ashley Brogan, Jeffrey Berman, et al.
JACC. Cardiooncology|January 29, 2021
Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell TransplantationGraham Lohrmann, Monica Arun Patel, Dina Brauneis, et al.
European Heart Journal. Cardiovascular Imaging|December 15, 2016
Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosisFrancesco Salinaro, Hans K Meier-Ewert, Edward J Miller, et al.
Circulation|January 24, 2008
Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart StudyGuido A Rosito, Joseph M Massaro, Udo Hoffmann, et al.
Pageof 11